Tarsus Pharmaceuticals Inc TARS

‎$‎73.26-1.64(-2.19%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Price Target

94.60

Based on analysts who covered TARS

Invest in Tarsus Pharmaceuticals Inc
Today

Create an eToro account to buy TARS stock on a secure, user-friendly, multi-asset trading platform.

Tarsus Pharmaceuticals Inc TARS

Buy TARS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Mitchells & Butlers PLC

Shanghai Electric Group Company Limited

MAX

*Past performance is not an indication of future results

Jump to:

About TARS >
How to Buy? >
Top Guides >

The Tarsus Pharmaceuticals Inc share price is stable this week.

The Tarsus Pharmaceuticals Inc share price today is ‎$‎73.26, reflecting a ‎-2.19‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of TARS is ‎$‎3.12B with an average volume in the last three months of 643558.62. The stock has a P/E ratio of -45.51 and a dividend yield of 0%. With the stock’s beta sitting at 0.73

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

TARS Key Metrics

Market Cap

‎$‎3.12B

Day’s Range

‎$‎71.71 - ‎$‎74.38

52W Range

‎$‎25.8 - ‎$‎84.87

Average Volume (3M)

643558.62

Price-Earnings Ratio

-45.51

Revenue

‎$‎451.36M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎73.26

EPS

‎$‎-1.61

Beta

0.73

How can I buy Tarsus Pharmaceuticals Inc stocks?

To purchase Tarsus Pharmaceuticals Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Tarsus Pharmaceuticals Inc (TARS) page and place an order to buy Tarsus Pharmaceuticals Inc.

Buy TARS

Looking for more information? Check out our guide on Academy.

What Is Tarsus Pharmaceuticals Inc?

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that specialises in developing transformative therapies to address rare, unmet medical needs. It implements its advanced research and treatment solutions across the US.

Tarsus operates in the healthcare sector with an emphasis on the pharmaceuticals industry. The scope of its services is vast, ranging from drug development to producing therapeutic treatments. It is known for its techniques, scientific expertise, and commitment to creating novel treatments for diseases with limited traditional treatment options.

Diversify your virtual portfolio by following TARS shares on eToro.

CEO

Bobak Azamian, MD, PhD

Employees

370

Founded

2017

Irvine, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Tarsus Pharmaceuticals Inc
Today

Create an eToro account to buy TARS stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Tarsus Pharmaceuticals Inc stock?

The current price of TARS is ‎$‎73.26.

What is Tarsus Pharmaceuticals Inc’s stock future price target?

The average price target for Tarsus Pharmaceuticals Inc is ‎$‎94.60. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Tarsus Pharmaceuticals Inc?

Analysts offer forecasts for Tarsus Pharmaceuticals Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Tarsus Pharmaceuticals Inc?

The market capitalisation of Tarsus Pharmaceuticals Inc is ‎$‎3.12B

Is Tarsus Pharmaceuticals Inc stock buy, sell or hold?

Based on 5 analysts offering recommendations for TARS in the last 3 months, the overall consensus is .

Daily Movers

Explore the biggest stocks movers on the market.